Tagged With Shire

Healthcare deals hit an all-time record in 2018. See the 7 biggest tie-ups that could change how we buy drugs and treat diseases.

Takeda is closing in on buying Adderall maker Shire for $64 billion in pharma's biggest deal of the year

Takeda's considering turning up the heat on its bid for Shire

A bidding war for the maker of Adderall stalled out after just 4 hours

Here's how the CEO of a $50 billion drugmaker sees tech companies 'disrupting' healthcare

Why the CEO of a $50 billion company thinks you should look to Roger Federer for career inspiration

Here's what the 59-year-old CEO of a $50 billion healthcare company does to stay fit

The CEO of a $50 billion company explains why big-time dealmaking has dropped

Here's what the CEO of a $50 billion drug company wants out of health reform

The first mega takeover of 2016 just landed

The first massive pharma takeover of 2016 is already approaching

FTSE 100 CLOSE -- what you need to know